Park, Hannah Lui

TitleAssistant Professor In Residence
InstitutionUniversity of California, Irvine
Address1001 Health Sciences Road
CA 92697-3950
Phone(949) 824-2651
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Park H, Chang J, Lal G, Lal K, Ziogas A, Anton-Culver H. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ. Clin Breast Cancer. 2018 Apr; 18(2):e179-e185. PMID: 28941977.
      View in: PubMed
    2. Ma H, Xu X, Clague J, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park H, Sullivan-Halley J, Neuhausen SL, Bernstein L. Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study. Breast Cancer Res. 2016 06 17; 18(1):62. PMID: 27317095.
      View in: PubMed
    3. Park H, Shrewsbury RP. Student Evaluation of Online Pharmaceutical Compounding Videos. Am J Pharm Educ. 2016 Mar 25; 80(2):30. PMID: 27073283; PMCID: PMC4827581.
    4. Park H, Ziogas A, Chang J, Desai B, Bessonova L, Garner C, Lee E, Neuhausen SL, Wang SS, Ma H, Clague J, Reynolds P, Lacey JV, Bernstein L, Anton-Culver H. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study. BMC Cancer. 2016 Jan 12; 16:14. PMID: 26758508.
      View in: PubMed
    5. Park H, Tran SM, Lee J, Goodman D, Ziogas A, Kelly R, Larsen KM, Alvarez A, Tannous C, Strope J, Lynch W, Anton-Culver H. Clinical Implementation of a Breast Cancer Risk Assessment Program in a Multiethnic Patient Population: Which Risk Model to Use? Breast J. 2015 Sep-Oct; 21(5):562-4. PMID: 26227105.
      View in: PubMed
    6. Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, Martin LW, Millen AE, Park H, Rosal MC, Shikany JM, Shivappa N, Ockene JK, Hebert JR. Construct validation of the dietary inflammatory index among postmenopausal women. Ann Epidemiol. 2015 Jun; 25(6):398-405. PMID: 25900255.
      View in: PubMed
    7. Truong L, Park H, Chang SS, Ziogas A, Neuhausen SL, Wang SS, Bernstein L, Anton-Culver H. Human Nail Clippings as a Source of DNA for Genetic Studies. Open J Epidemiol. 2015 Feb 01; 5(1):41-50. PMID: 26180661.
      View in: PubMed
    8. Goodman D, Park H, Stefanick M, Hingle M, Lamonte M, LeBlanc E, Johnson K, Desai M, Anton-Culver H. Self-recalled Youth Physical Activity and Postmenopausal Cardiovascular Disease. Health Behav Policy Rev. 2014 Nov; 1(6):472-483. PMID: 26523282.
      View in: PubMed
    9. Parker DR, Lu B, Sands-Lincoln M, Kroenke CH, Lee CC, O'Sullivan M, Park H, Parikh N, Schenken RS, Eaton CB. Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the women's health initiative. Ann Fam Med. 2014 Jul; 12(4):302-9. PMID: 25024237; PMCID: PMC4096466.
    10. Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park H, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Res. 2013 Dec 10; 15(6):R115. PMID: 24326041; PMCID: PMC3978701.
    11. Goodman D, Park H, Stefanick M, LeBlanc E, Bea J, Qi L, Kapphahn K, Lamonte M, Manini T, Desai M, Anton-Culver H. Relation between self-recalled childhood physical activity and adult physical activity: The women's health initiative. Open J Epidemiol. 2013 Nov 01; 3(4):224-231. PMID: 26877895.
      View in: PubMed
    12. Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park H, Thomas F, Wactawski-Wende J, Simon MS. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1868-76. PMID: 23975947; PMCID: PMC3889164.
    13. Brait M, Ling S, Nagpal JK, Chang X, Park H, Lee J, Okamura J, Yamashita K, Sidransky D, Kim MS. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012; 7(9):e44951. PMID: 23028699; PMCID: PMC3459978.
    14. Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, Johnson KC, LeBlanc E, Lee C, La Croix AZ, Park H, Sims ST, Vitolins M, Wallace R. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative. Menopause. 2012 Sep; 19(9):980-8. PMID: 22781782; PMCID: PMC3428489.
    15. Taylor SM, Nevis KR, Park H, Rogers GC, Rogers SL, Cook JG, Bautch VL. Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels. Blood. 2010 Oct 21; 116(16):3108-17. PMID: 20664058; PMCID: PMC2974614.
    16. Kim MS, Louwagie J, Carvalho B, Terhaar Sive Droste JS, Park H, Chae YK, Yamashita K, Liu J, Ostrow KL, Ling S, Guerrero-Preston R, Demokan S, Yalniz Z, Dalay N, Meijer GA, Van Criekinge W, Sidransky D. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One. 2009 Aug 07; 4(8):e6555. PMID: 19662090; PMCID: PMC2717211.
    17. Ostrow KL, Park H, Hoque MO, Kim MS, Liu J, Argani P, Westra W, Van Criekinge W, Sidransky D. Pharmacologic unmasking of epigenetically silenced genes in breast cancer. Clin Cancer Res. 2009 Feb 15; 15(4):1184-91. PMID: 19228724; PMCID: PMC3082476.
    18. Tokumaru Y, Yamashita K, Kim MS, Park H, Osada M, Mori M, Sidransky D. The role of PGP9.5 as a tumor suppressor gene in human cancer. Int J Cancer. 2008 Aug 15; 123(4):753-9. PMID: 18512240; PMCID: PMC3069849.
    19. Park H, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D. DCC promoter hypermethylation in esophageal squamous cell carcinoma. Int J Cancer. 2008 Jun 01; 122(11):2498-502. PMID: 18302152.
      View in: PubMed
    20. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park H, Poeta ML, Jeronimo C, Henrique R, Lendvai A, Schuuring E, Begum S, Rosenbaum E, Ongenaert M, Yamashita K, Califano J, Westra W, van der Zee AG, Van Criekinge W, Sidransky D. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res. 2008 Apr 15; 68(8):2661-70. PMID: 18413733; PMCID: PMC3102297.
    21. Yamashita K, Kim MS, Park H, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol Cancer Res. 2008 Jan; 6(1):31-41. PMID: 18234960.
      View in: PubMed
    22. Jiang WW, Zahurak M, Zhou ZT, Park H, Guo ZM, Wu GJ, Sidransky D, Trink B, Califano JA. Alterations of GPI transamidase subunits in head and neck squamous carcinoma. Mol Cancer. 2007 Nov 21; 6:74. PMID: 18028549; PMCID: PMC2204038.
    23. Kim MS, Yamashita K, Chae YK, Tokumaru Y, Chang X, Zahurak M, Osada M, Park H, Chuang A, Califano JA, Sidransky D. A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1):6658-65. PMID: 18006766.
      View in: PubMed
    24. Liu JW, Kim MS, Nagpal J, Yamashita K, Poeta L, Chang X, Lee J, Park H, Jeronimo C, Westra WH, Mori M, Moon C, Trink B, Sidransky D. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Int J Cancer. 2007 Nov 01; 121(9):1994-2000. PMID: 17620329.
      View in: PubMed
    25. Osada M, Park H, Park MJ, Liu JW, Wu G, Trink B, Sidransky D. A p53-type response element in the GDF15 promoter confers high specificity for p53 activation. Biochem Biophys Res Commun. 2007 Mar 23; 354(4):913-8. PMID: 17276395; PMCID: PMC1975780.
    26. Jiang WW, Zahurak M, Goldenberg D, Milman Y, Park H, Westra WH, Koch W, Sidransky D, Califano J. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006 Dec 01; 119(11):2673-6. PMID: 16991120.
      View in: PubMed
    27. Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, Zhao M, Jerónimo C, Henrique R, Nayak CS, Park H, Brait MR, Liu C, Zhou S, Koch W, Fazio VM, Ratovitski E, Trink B, Westra W, Sidransky D, Moon CS, Califano JA. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res. 2006 Oct 01; 66(19):9401-7. PMID: 17018594.
      View in: PubMed
    28. Yamashita K, Park H, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. PGP9.5 methylation in diffuse-type gastric cancer. Cancer Res. 2006 Apr 01; 66(7):3921-7. PMID: 16585221.
      View in: PubMed
    29. Kim MS, Yamashita K, Baek JH, Park H, Carvalho AL, Osada M, Hoque MO, Upadhyay S, Mori M, Moon C, Sidransky D. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer. Cancer Res. 2006 Apr 01; 66(7):3409-18. PMID: 16585162.
      View in: PubMed
    30. Osada M, Park H, Nagakawa Y, Begum S, Yamashita K, Wu G, Kim MS, Trink B, Sidransky D. A novel response element confers p63- and p73-specific activation of the WNT4 promoter. Biochem Biophys Res Commun. 2006 Jan 27; 339(4):1120-8. PMID: 16343436.
      View in: PubMed
    31. Osada M, Nagakawa Y, Park H, Yamashita K, Wu G, Kim MS, Fomenkov A, Trink B, Sidransky D. p63-specific activation of the BPAG-1e promoter. J Invest Dermatol. 2005 Jul; 125(1):52-60. PMID: 15982302.
      View in: PubMed
    32. Osada M, Park H, Nagakawa Y, Yamashita K, Fomenkov A, Kim MS, Wu G, Nomoto S, Trink B, Sidransky D. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol. 2005 Jul; 25(14):6077-89. PMID: 15988020; PMCID: PMC1168821.
    33. Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park H, Kim MS, Osada M, Mori M, Sidransky D. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res. 2005 Jun 01; 65(11):4963-8. PMID: 15930319.
      View in: PubMed
    34. Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park H, Trink B, Sidransky D, Fomenkov A, Ratovitski EA. Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype. Cell Cycle. 2004 Dec; 3(12):1587-96. PMID: 15539951.
      View in: PubMed